Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003134971 | SCV003816710 | uncertain significance | not provided | 2020-12-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003134971 | SCV004184752 | uncertain significance | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003778749 | SCV004610239 | uncertain significance | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2022-12-02 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This missense change has been observed in individual(s) with PLEC-related conditions (PMID: 27234031). This variant is present in population databases (rs782235531, gnomAD 0.01%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 3794 of the PLEC protein (p.Ala3794Thr). |